Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Emerging Leaders Prize recognises future leaders in hepatitis research

General news

Three outstanding hepatitis researchers have been announced today as winners of the Medical Research Foundation’s seventh Emerging Leaders Prize.

A global collaboration to develop next-generation COVID-19 and flu vaccines

General news

Today Oxford University has launched a new global collaboration backed by £8 million funding from UK Research and Innovation (UKRI). The project will be spearheaded by Professor Teresa Lambe, Professor of Vaccinology and Immunology and Calleva Head of Vaccine Immunology in the Department of Paediatrics and Professor Paul Klenerman, Sidney Truelove Professor of Gastroenterology and Director of the Translational Gastroenterology Unit at NDM, both of whom are Principal Investigators at NDM’s Pandemic Sciences Institute.

Study reveals vaccine response in patients with impaired immune systems

General news

Updated data from the ongoing OCTAVE trial, a collaboration between the Universities of Glasgow, Birmingham and Oxford, show for the first time that most clinically at-risk patients with a range of immunocompromised or immunosuppressed conditions in the UK were protected from severe COVID by the vaccination programme.

3.4 million assays run by NDM’s serology platform

General news

Within weeks of the pandemic starting, the Nuffield Department of Medicine (NDM) began antibody testing as part of the UK’s ONS COVID-19 Infection Survey. The platform successfully tested millions of blood samples over three years, providing invaluable information on how vaccinations and previous infections affect the chance of getting COVID-19 again.

Landmark antibody study to test immune responses against COVID-19

General news

Thousands of immunosuppressed people, including patients at Oxford University Hospitals (OUH), have the chance to take part in a landmark new study investigating which people are still at the greatest risk of COVID-19 infection after vaccination.

COVID-19: accelerating testing with robotics

General news

Kevin Chau, a PhD student on our National PhD Training Programme in AMR Research, has contributed to the pandemic response as part of the Modernising Medical Microbiology team at John Radcliffe Hospital in Oxford. In a new blog post, he describes the experience.

Three NDM researchers awarded Associate Professorships

General news

We are delighted to announce that three researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

Forbes Under 30 List

General news

Andreas Halner has been added to the Forbes Under 30 list

Paediatric IBD BioResource opens to support vital research

General news

A new National Institute for Health and Care Research (NIHR) BioResource aimed at investigating inflammatory bowel disease (IBD) in children has opened, with the NIHR Oxford BRC playing a key role.

Low Back Pain Trial

General news

The Oxford Bone Infection Research Group NDMOxford is recruiting patients into a new clinical trial for patients with chronic low back pain. To find out more visit http://lowbackpainstudy.co.uk

Oxford academics named NIHR Senior Investigators

General news

Seven academics in Oxford have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their outstanding leadership in research.

Monitoring Populations at risk from Coronavirus

General news

Emma Pritchard, Statistician and PhD student shares her work with ONS on Coronavirus statistics.

Oxford and Oracle partner to speed identification of COVID-19 variants

General news

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Finding our Way - An NHS Tribute Garden

General news

‘Finding Our Way – An NHS Tribute Garden’ is a celebration of the incredible efforts of the thousands of people who fought – and are still fighting - the COVID-19 pandemic on our behalf. Designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.

T-cell ‘training grounds’ behind robust immune system response seen in adenovirus vaccines

General news

Writing in the journal Nature Immunology, they detail an investigation into one of the key features of adenovirus vaccines – their ability to generate strong and sustained populations of the ‘killer’ T-cell element of the immune system.

Immunology and AI drug discovery partnership agreed with Sensyne Health

General news

The University has signed an agreement with Sensyne Health to conduct a multi-omics drug discovery research project in asthma. The project will be led by Dr Timothy Hinks at his team at the Nuffield Department of Medicine’s Respiratory Medicine Unit.

Study reveals COVID-19 vaccine response in patients with impaired immune systems

General news

A national study has found that a significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions, mount a low, or undetectable, immune response after two doses of the same COVID-19 vaccine.

UNDERSTANDING THE IMMUNITY OF RECOVERED COVID-19 PATIENTS

General news

Two vital research programmes taking place at the University of Oxford may hold the key to understanding the immunity of recovered Covid-19 patients. The data will also be used by Professor Sarah Walker at the University of Oxford who is working with the Office for National Statistics on the COVID-19 Infection Survey.

Prof Sarah Walker receives OBE

General news

Prof Walker, Professor of Medical Statistics and Epidemiology at the University of Oxford’s Nuffield Department of Medicine, was recognised for services to academia and the COVID-19 response and will receive an OBE.

Evaluation of LamPORE rapid tests for Covid-19 show high levels of diagnostic sensitivity

General news

Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. It combines loop-mediated isothermal amplification with nanopore sequencing. This technology has the potential to analyse thousands of samples per day on a single instrument.

Load More